OR13Z3P

Across TCGA pan-cancer cohorts, OR13Z3P RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated OR13Z3P data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher OR13Z3P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated OR13Z3P expression acts as an unfavorable survival marker.

STAD, KIRC, and ACC are the cancer types where OR13Z3P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Tertile	IV	0.097	0.509	.001	39	view →
KIRC	DFS	Tertile	IV	0.127	0.619	.008	36	view →
ACC	DFS	Tertile	All	0.066	0.667	.002	36	view →
CESC	OS	Tertile	II,III,IV	0.524	0.829	.010	30	view →
COAD	OS	Tertile	IV	0.123	0.681	.008	21	view →
OV	DFS	Tertile	III,IV	0.291	0.379	.029	18	view →
HNSC	OS	Tertile	All	0.177	0.710	.016	18	view →
PRAD	OS	Tertile	All	0.685	0.887	.022	6	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

OR13Z3P–STAD (OS)

Open the STAD breakdown →